Binnopharm Group (part of Sistema) and Sartorius, one of the leading global manufacturers of equipment for the biopharmaceutical industry, have signed a strategic partnership...
The first Russian direct-acting intravenous antiviral drug Areplivir® (favipiravir) received marketing authorization certificate and its supply to hospitals in all regions will start by...
In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III...
Binnopharm Group, a holding company that combines Sistema’s pharmaceutical assets, announces that the Expert RA rating agency has assigned an expected ruA credit rating...
The Ministry of Health of the Russian Federation has issued the 12th version of the Temporary guidelines for the prevention, diagnosis and treatment of...
Ritonavir, used for the treatment of HIV infection and viral hepatitis C, received the marketing authorization certificate and became the first drug in the...